Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Thomas Serzan, M.D.

Concepts (28)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Michael Serzan's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Michael Serzan has written about over time.
Coronavirus, 1 publications between 2020 and 2020, average publication date April 2020. Coronavirus Infections, 1 publications between 2020 and 2020, average publication date April 2020. Immunotherapy, 1 publications between 2020 and 2020, average publication date April 2020. Pneumonia, Viral, 1 publications between 2020 and 2020, average publication date April 2020. Steroids, 1 publications between 2020 and 2020, average publication date April 2020. Melanoma, 2 publications between 2020 and 2023, average publication date October 2021. Neoplasm Recurrence, Local, 1 publications between 2022 and 2022, average publication date June 2022. Carcinoma, Non-Small-Cell Lung, 1 publications between 2022 and 2022, average publication date June 2022. Opportunistic Infections, 1 publications between 2022 and 2022, average publication date June 2022. Pneumocystis carinii, 1 publications between 2022 and 2022, average publication date June 2022. Pneumonia, Pneumocystis, 1 publications between 2022 and 2022, average publication date June 2022. Carcinoma, Renal Cell, 2 publications between 2022 and 2023, average publication date December 2022. Kidney Neoplasms, 2 publications between 2022 and 2023, average publication date December 2022. Protein Kinase Inhibitors, 1 publications between 2023 and 2023, average publication date May 2023.

To see the data from this visualization as text, click here.
Serzan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (28)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.